Tender detail
Open-house pharmaceutical discount agreements for Piribedil, ATC N04BC08
Summary
AOK Bayern intends to conclude identical, non-exclusive pharmaceutical discount agreements with interested pharmaceutical companies for the active ingredient Piribedil (ATC N04BC08). The earliest contract start date is 1 January 2027, and all agreements end on 31 December 2028; contracts may be concluded during that period, no later than 3 November 2028.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.